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Introduction: Little is known about the connection between tumor reductive surgery and
quality of life in patients diagnosed with epithelial ovarian cancer (EOC). It is therefore
unclear whether it is the surgery or the disease itself that is the main factor affecting the
patients quality of life. The aim of the current study was to examine information requested
and perceived about tumor reductive surgery in patients with newly diagnosed advanced
EOC. Engaging the user perspective ensures focus on areas considered relevant and
important by patients.
Materials and Methods: Participants were recruited through the The Norwegian National
Gynaecological Patient Organization. They had all received surgical treatment for
advanced ovarian cancer at Norwegian hospitals. Main topics in the focus group interviews
was to explore the experiences of surgery. One focus group was formed and interviews
were moderated by two members of the research team using a semi-structured interview
format. A total of three sessions with this focus group has been done. The focus group
interviews were audiotaped and transcribed using a meaning condensation analysis.
Preliminary findings were shared with the participants for validation before further analysis.
Conclusion:The focus group discussions revealed weaknesses in information given
before treatment of advanced ovarian cancer. Guidelines on how to inform the patients
should include user involved research.
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What you should know about tumor reductive surgery in 
advanced ovarian cancer 
– Clinical recommendations from a patient perspective 
Results: Five women 
were asked and 
agreed to participate in 
the focus group 
interviews. Two major 
themes was found, but 
with different 
experiences. These 
themes were (a) 
communication gap 
between the time of 
diagnosis and surgery, 
and (b) insufficient 
information given 
about surgical side-
effects
